Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 72, Issue 4, Pages 553-562
Publisher
Wiley
Online
2010-12-30
DOI
10.1111/j.1365-2125.2010.03899.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Corticosteroid Therapy for Acquired F VIII:C Inhibitors
- (2010) J. A. Spero et al. BRITISH JOURNAL OF HAEMATOLOGY
- Clinical issues in inhibitors
- (2010) J. ASTERMARK et al. HAEMOPHILIA
- Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review
- (2010) A. IORIO et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Safety of Recombinant Activated Factor VII in Randomized Clinical Trials
- (2010) Marcel Levi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prophylaxis in Congenital Hemophilia with Inhibitors: The Role of Recombinant Activated Factor VII
- (2010) Massimo Franchini et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- The Multifactorial Etiology of Inhibitor Development in Hemophilia: Genetics and Environment
- (2010) Samantha Gouw et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Laboratory Identification of Factor Inhibitors: The Perspective of a Large Tertiary Hemophilia Center
- (2010) Geoffrey Kershaw et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Recombinant Activated Factor VII: Mechanisms of Action and Current Indications
- (2010) Massimo Franchini et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Systematic review of efficacy of rFVIIa and aPCC treatment for hemophilia patients with inhibitors
- (2009) Chris Knight et al. ADVANCES IN THERAPY
- Advances in the understanding of acquired haemophilia A: implications for clinical practice
- (2009) Peter W. Collins et al. BRITISH JOURNAL OF HAEMATOLOGY
- International recommendations on the diagnosis and treatment of patients with acquired hemophilia A
- (2009) A. Huth-Kuhne et al. HAEMATOLOGICA
- The North American Immune Tolerance Registry: contributions to the thirty-year experience with immune tolerance therapy
- (2009) D. DIMICHELE HAEMOPHILIA
- Efficacy of recombinant activated factor VII vs. activated prothrombin complex concentrate for patients suffering from haemophilia complicated with inhibitors: a Bayesian meta-regression
- (2009) M. J. TREUR et al. HAEMOPHILIA
- Extracorporeal Immunoadsorption for the Treatment of Coagulation Inhibitors
- (2009) Massimo Franchini et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Acquired factor VIII inhibitors
- (2008) M. Franchini et al. BLOOD
- Laboratory, clinical and therapeutic aspects of acquired hemophilia A
- (2008) Massimo Franchini et al. CLINICA CHIMICA ACTA
- Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors
- (2008) K. FISCHER et al. HAEMOPHILIA
- Immune tolerance with rituximab in congenital haemophilia with inhibitors: a systematic literature review based on individual patients’ analysis
- (2008) M. FRANCHINI et al. HAEMOPHILIA
- Single 270 μg kg−1-dose rFVIIa vs. standard 90 μg kg−1-dose rFVIIa and APCC for home treatment of joint bleeds in haemophilia patients with inhibitors: a randomized comparison
- (2008) G. YOUNG et al. HAEMOPHILIA
- Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors
- (2008) W. K. HOOTS et al. HAEMOPHILIA
- Back to the future: a recent history of haemophilia treatment
- (2008) P. M. MANNUCCI HAEMOPHILIA
- International survey of attitudes towards secondary prophylaxis with recombinant factor VIIa in haemophilia A patients with inhibitors
- (2008) P. M. MANNUCCI et al. HAEMOPHILIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More